Signed in as:
filler@godaddy.com
By accessing this page, you confirm that you are an accredited investor.
Maman Biomedical is developing the world’s first needle-free hormone delivery platform — starting with fertility, a $10B+ global market.
Why Now
1 in 6 people face infertility, and IVF requires 20+ painful injections per cycle. Hormone therapy is a $50B+ per year rapidly growing market — yet no one has solved needle-free drug delivery for large molecules. Until now.
Why Us?
Round Details
- Raising: $500K Pre-Seed (Tranche 1 now open)
- Use of funds: Port clinical validation, Patch preclinical studies, regulatory prep
- Timeline: Port → market entry by 2027; Patch → TRL 4–5 in 12–18 months
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.